Motac Neuroscience Ltd

Motac Neuroscience Ltd specializes in providing highly-specialized preclinical research services to the pharmaceutical and biotechnology industries, supporting the discovery and development of innovative therapies for neurological and psychiatric disorders. With extensive expertise and world-class research capabilities, Motac Neuroscience Ltd excels in neurodegenerative conditions, particularly Parkinson’s disease, other movement disorders, and cognitive disorders. The primary address for Motac Neuroscience Ltd is in Bordeaux, France.

Motac Neuroscience Ltd focuses on preclinical proof-of-concept and efficacy studies, offering access to top-tier models of these conditions. Underpinned by strong scientific understanding, the company operates within a commercial environment that emphasizes quality and timeliness. Motac Neuroscience Ltd has a rich history of contributions to understanding brain mechanisms mediating movement disorders, leading to new treatments.

Furthermore, Motac Neuroscience Ltd possesses an intellectual property portfolio that includes new chemical entities and novel therapeutic targets for treating movement disorders. These assets are being developed through strategic alliances and partnerships. Motac Neuroscience Ltd is committed to advancing the field of neuroscience through cutting-edge research and collaborative efforts. We invite the manager of Motac Neuroscience Ltd to create a customized and exclusive company showcase and product listing on our platform.